These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 7049073)
1. Pharmacokinetics and bacteriological efficacy of N-formimidoyl thienamycin in experimental Escherichia coli meningitis. Patamasucon P; McCracken GH Antimicrob Agents Chemother; 1982 Mar; 21(3):390-2. PubMed ID: 7049073 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and bacteriological efficacy of mezlocillin in experimental Escherichia coli and Listeria monocytogenes meningitis. Odio C; Thomas ML; McCracken GH Antimicrob Agents Chemother; 1984 Apr; 25(4):427-32. PubMed ID: 6375552 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of N-formimidoyl thienamycin and influence of a renal dipeptidase inhibitor in experimental meningitis. Washburn DE; Perfect JR; Durack DT J Antimicrob Chemother; 1983 Jul; 12(1):39-45. PubMed ID: 6578210 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and bacteriological effect of ceftazidime in experimental Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli meningitis. Sakata Y; Boccazzi A; McCracken GH Antimicrob Agents Chemother; 1983 Feb; 23(2):213-7. PubMed ID: 6340600 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin. Horadam VW; Smilack JD; Montgomery CL; Werringloer J Antimicrob Agents Chemother; 1980 Oct; 18(4):557-61. PubMed ID: 6934707 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of piperacillin-tazobactam in experimental meningitis caused by a beta-lactamase-producing strain of K1-positive Escherichia coli. Kern W; Kennedy SL; Sachdeva M; Sande ER; Gunderson D; Täuber MG Antimicrob Agents Chemother; 1990 May; 34(5):697-701. PubMed ID: 2163241 [TBL] [Abstract][Full Text] [Related]
7. Aztreonam therapy in experimental meningitis due to Haemophilus influenzae type b and Escherichia coli K1. McCracken GH; Sakata Y; Olsen KD Antimicrob Agents Chemother; 1985 Apr; 27(4):655-6. PubMed ID: 3890733 [TBL] [Abstract][Full Text] [Related]
8. Intrathecal penetration of N-formimidoyl thienamycin in normal rabbits: potentiation by coadministration of renal dipeptidase enzyme inhibitor. Chow AW; Finlay KR; Stiver HG; Carlson CL Antimicrob Agents Chemother; 1983 Apr; 23(4):634-6. PubMed ID: 6574725 [TBL] [Abstract][Full Text] [Related]
9. Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa. Corrado ML; Landesman SH; Cherubin CE Antimicrob Agents Chemother; 1980 Dec; 18(6):893-6. PubMed ID: 6263178 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and bacteriological efficacy of ticarcillin-clavulanic acid (timentin) in experimental Escherichia coli K-1 and Haemophilus influenzae type b meningitis. Syrogiannopoulos GA; Al-Sabbagh A; Olsen KD; McCracken GH Antimicrob Agents Chemother; 1987 Sep; 31(9):1296-300. PubMed ID: 3314696 [TBL] [Abstract][Full Text] [Related]
11. Comparison of netilmicin with gentamicin in the therapy of experimental Escherichia coli meningitis. Scheld WM; Brown RS; Sande MA Antimicrob Agents Chemother; 1978 Jun; 13(6):899-904. PubMed ID: 354518 [TBL] [Abstract][Full Text] [Related]
12. Once-daily gentamicin therapy for experimental Escherichia coli meningitis. Ahmed A; París MM; Trujillo M; Hickey SM; Wubbel L; Shelton SL; McCracken GH Antimicrob Agents Chemother; 1997 Jan; 41(1):49-53. PubMed ID: 8980753 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans. Norrby SR; Alestig K; Ferber F; Huber JL; Jones KH; Kahan FM; Meisinger MA; Rogers JD Antimicrob Agents Chemother; 1983 Feb; 23(2):293-9. PubMed ID: 6573156 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and antibacterial efficacy of cefpirome (HR 810) in experimental Escherichia coli and Haemophilus influenzae type b meningitis. Jafari HS; Sáez-Llorens X; Ramilo O; Shelton SL; McCracken GH Antimicrob Agents Chemother; 1991 Feb; 35(2):220-3. PubMed ID: 2024953 [TBL] [Abstract][Full Text] [Related]
15. Comparison of four aminoglycoside antibiotics in the therapy of experimental E. coli meningitis. Strausbaugh LJ; Mandaleris CD; Sande MA J Lab Clin Med; 1977 Apr; 89(4):692-701. PubMed ID: 321713 [TBL] [Abstract][Full Text] [Related]
16. Antibiotic therapy of fulminant E. coli K1 sepsis in infant rabbits. Law BJ; Rettig PJ; Marks MI Pediatr Res; 1984 Apr; 18(4):314-7. PubMed ID: 6371694 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of aztreonam in experimental bacterial meningitis and cerebritis. Scheld WM; Brodeur JP; Gratz JC; Foresman P; Rodeheaver G Antimicrob Agents Chemother; 1983 Nov; 24(5):682-8. PubMed ID: 6362552 [TBL] [Abstract][Full Text] [Related]
18. Correlation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitis. Decazes JM; Ernst JD; Sande MA Antimicrob Agents Chemother; 1983 Oct; 24(4):463-7. PubMed ID: 6316841 [TBL] [Abstract][Full Text] [Related]